Is This the Start of a VIVUS Comeback?

Drugmaker VIVUS  (NASDAQ: VVUS  ) has been struggling lately; initial sales from the launch of its obesity drug Qsymia failed to impress investors, and that resulted in a big drop in November. Today, however, shares were up by 4%. Could this be a sign that Qsymia sales are finally moving in the right direction?

In this video, Motley Fool health care analysts Max Macaluso and Brenton Flynn discuss what may be behind the share-price bump, and how it may affect not only VIVUS, but also some of the company's biggest competitors -- namely Arena Pharmaceuticals  (NASDAQ: ARNA  ) and Orexigen  (NASDAQ: OREX  ) .

If you're looking for more information on both of these companies, grab copies of our premium research reports on Arena Pharmaceuticals and VIVUS today. In the reports, our senior biotech analyst, Brian Orelli, Ph.D. breaks down each company's strengths and weaknesses and explains the critical issues you need to know about. News in this space moves fast, so both reports come with a full year of updates. To learn more about Arena and VIVUS, click here today.

Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2147487, ~/Articles/ArticleHandler.aspx, 10/20/2016 4:10:50 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,185.26 -17.36 -0.10%
S&P 500 2,141.21 -3.08 -0.14%
NASD 5,246.30 -0.11 0.00%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/20/2016 3:55 PM
VVUS $1.11 Up +0.01 +0.91%
VIVUS CAPS Rating: **
ARNA $1.60 Up +0.07 +4.58%
Arena Pharmaceutic… CAPS Rating: **
OREX $2.78 Up +0.07 +2.58%
Orexigen Therapeut… CAPS Rating: *